APA (7th ed.) Citation

HÉ, C., S, J., AL, P., J, S., A, E. T., F, V., . . . J, S. (2025). Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome. Nature communications, 17(1), 892. https://doi.org/10.1038/s41467-025-67611-w

Chicago Style (17th ed.) Citation

HÉ, Châtel-Soulet, et al. "Thrombopoietin Increases Susceptibility for EVI1 + KMT2A-MLLT3-driven AML Expressing Stem Cell Genes Linked to Poor Outcome." Nature Communications 17, no. 1 (2025): 892. https://doi.org/10.1038/s41467-025-67611-w.

MLA (9th ed.) Citation

HÉ, Châtel-Soulet, et al. "Thrombopoietin Increases Susceptibility for EVI1 + KMT2A-MLLT3-driven AML Expressing Stem Cell Genes Linked to Poor Outcome." Nature Communications, vol. 17, no. 1, 2025, p. 892, https://doi.org/10.1038/s41467-025-67611-w.